Answers are grounded in this paper and cite their sources.
A platform for capture and release of circulating tumor cells (CTCs) is demonstrated by utilizing aptamer grafted silicon nanowires. Here, single-stranded DNA-aptamers are generated via the Cell-SELEX process to serve as capture agents, allowing specific capture and release of non-small cell lung cancer (NSCLC) CTCs from whole-blood samples with minimum contamination and negligible disruption to CTC viability and functions.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: